Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing2.

Ajenifuja, Kayode Olusegun; Belinson, Jerome; Goldstein, Andrew; Desai, Kanan T; de Sanjose, Silvia; Schiffman, Mark

Ajenifuja, Kayode Olusegun; Belinson, Jerome; Goldstein, Andrew; Desai, Kanan T; de Sanjose, Silvia; Schiffman, Mark.

Afiliação

Ajenifuja KO; OAUTHC, Ile Ife, Nigeria.
Belinson J; Women's Health Institute, Cleveland Clinic, Cleveland, OH USA.
Goldstein A; Centers for Vulvovaginal Disease, Washington, DC USA.
Desai KT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Clinical Epidemiology Unit, Clinical Genetics Branch, 9609 Medical Center Drive Room 6E544, Rockville, MD 20850 USA.
de Sanjose S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Clinical Epidemiology Unit, Clinical Genetics Branch, 9609 Medical Center Drive Room 6E544, Rockville, MD 20850 USA.
Schiffman M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Clinical Epidemiology Unit, Clinical Genetics Branch, 9609 Medical Center Drive Room 6E544, Rockville, MD 20850 USA.

Infect Agent Cancer ; 15: 61, 2020.

Article em En | MEDLINE | ID: mdl-33072179

Palavras-chave

COVID-19; Cervical screening; HPV; Self-sampling; Triage

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Screening_studies Idioma: En Revista: Infect Agent Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Nigéria País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google